Surrozen (SRZN) Change in Receivables (2024 - 2026)
Surrozen (SRZN) posted quarterly Change in Receivables of $5.0 million for Q1 2026, up 345.22% quarter-over-quarter from -$2.0 million in Q4 2025.
Analysis
Surrozen (SRZN) Change in Receivables (2024 - 2026) Analysis & Trends
Surrozen's Change in Receivables history runs 3 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, Change in Receivables changed N/A year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $3.0 million (changed N/A YoY), while the FY2025 annual figure was -$2.0 million, changed N/A from the prior year.
- Change in Receivables for Q1 2026 stood at $5.0 million, up from -$2.0 million in the prior quarter.
- The five-year high for Change in Receivables was $10.0 million in Q3 2024, with the low at -$10.0 million in Q4 2024.
- The 3-year median for Change in Receivables is $0.0 (2025), against an average of $493500.0.
- Peak annual rise in Change in Receivables reached 79.61% in 2025, while the deepest fall reached 97.5% in 2025.
- Surrozen's Change in Receivables stood at -$10.0 million in 2024, then surged by 79.61% to -$2.0 million in 2025, then soared by 345.22% to $5.0 million in 2026.
- Business Quant data shows SRZN's Change in Receivables at $5.0 million in Q1 2026, -$2.0 million in Q4 2025, and $250000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Surrozen | 263.35 Mn | 263.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | -10.00 Mn |
| Sep 30, 2024 | 10.00 Mn |